COVID-19 Vaccine Comparison Table

1 COVID-19 Vaccine Comparison Table (Full Version). Pfizer-BioNTech, Moderna, and Johnson & Johnson Pediatric Pfizer Adult Pfizer Moderna Johnson & Johnson1. Age 5-11 years old 12 years and older 18 years and older 18 years and older Type of Vaccine mRNA mRNA mRNA Viral Vector Vial Cap Color ORANGE GRAY RED BLUE. Doses Per vial 10 doses 6 doses 10 doses 5 doses Minimum Package 100 doses 300 doses 100 doses 50 doses Quantity (Direct Ship). NDC # 59267-1055-04 59267-1025-04 80777-0273-99 59676-0580-15. CVX 218 217 212 207. NDIIS name COVID19 (Pfizer) 5-11yrs COVID19 PFZ-TRIS 12+ COVID19 (Moderna) COVID19 (Janssen). STORAGE CONDITIONS. 2. Ultra-Low-Temperature 12 months 12 months2 DO NOT STORE AT THIS DO NOT STORE AT THIS.

2 Freezer TEMPERATURE TEMPERATURE. [-90 C to -60 C (-130 F. to -76 F)]. Freezer DO NOT STORE AT THIS DO NOT STORE AT THIS 6 months DO NOT STORE AT THIS. [-50 C to -15 C (-58 F TEMPERATURE TEMPERATURE TEMPERATURE. to 5 F)]. refrigerator 10 weeks 10 weeks 30 days Until expiration [2 C to 8 C (36 F to 46 F)]. Room Temperature 12 hours prior to dilution 12 hours prior to first 24 hours 12 hours [8 C to 25 C (46 F to puncture 77 F)]. Updated 6/01/22. After First Puncture Discard after 12 hours Discard after 12 hours Discard after 12 hours Discard after 6 hours (if [2 C to 25 C (35 F to refrigerated) or 2 hours (if at 77 F)] room temperature). Vaccine PREPARATION. Thawing Thaw in the refrigerator Thaw in the refrigerator Thaw in refrigerated Thaw in refrigerated [2 C to 8 C (35 F to [2 C to 8 C (35 F to conditions between 2 C to conditions between 2 C to 46 F)].)]

3 A carton of 10 46 F)]. A carton of 10 8 C (36 to 46 F) for 2 8 C (36 to 46 F) for 2 hours. vials may take up to 6 vials may take up to 6 hours and 30 minutes. Let Let vial stand at room hours to thaw. hours to thaw. vial stand at room temperature for 15 minutes temperature for 15 before administering. Thaw at room temperature Thaw at room temperature minutes before for 30 minutes. for 30 minutes. administering. or or Thawing Vaccine at room temperature (maximally Thaw at room temperature 25 C/77 F). A carton of 10 vials for 1 hour. will take ~2 hours, and individual vials will take approximately ~1 hour. Preparation Before dilution, mix by Before use, mix by Vaccine vial should be Before withdrawing each dose inverting Vaccine vial inverting Vaccine gently 10 gently swirled prior to of Vaccine , carefully mix gently 10 times.

4 Times. drawing up the Vaccine contents of the multi-dose vial DO NOT SHAKE. DO NOT SHAKE. dose. by swirling gently in an DO NOT SHAKE. upright position for 10. Inspect the liquid in the Prior to mixing, the thawed seconds. vial prior to dilution. The Vaccine may contain white No dilution is necessary. DO NOT SHAKE. liquid is a white to off- to off-white opaque DO NOT DILUTE. white suspension and may amorphous particles. No dilution is necessary. contain opaque amor- Record the date and time DO NOT DILUTE. phous particles. No dilution is necessary. of the vial puncture on the DO NOT DILUTE. vial's label. Record the date and time of Vaccine will need to be vial puncture on the vial's reconstituted with label.

5 Of diluent that is supplied Updated 6/01/22. in the ancillary kits. Only Record the date and time this diluent can be used to of the vial puncture on the reconstitute the Vaccine . vial's label. After dilution the vial should be gently inverted 10 times. DO NOT SHAKE. Record the date and time of dilution on the vial's label. Do not use if liquid is discolored or if other particles are observed. Amount of Diluent mL sterile Sodium DO NOT DILUTE DO NOT DILUTE DO NOT DILUTE. Needed Per Vial Chloride Injection PRIMARY SERIES. Authorized for a Yes Yes Yes Yes1. Primary Series? Number of Doses in 2 doses 2 doses 2 doses 1 dose Primary Series Dose 10 mcg 30 mcg 100 mcg N/A.

6 Dose volume mL mL mL Primary Series Interval 21 days 21 days 28 days N/A. ADDITIONAL DOSE3 (IMMUNOCOMPROMISED). Authorized for an Yes Yes Yes NO. Additional Dose? Recommendation for CDC recommends that CDC recommends that CDC recommends that CDC recommends that people Additional Dose3 people (ages 5-11) with people (ages 12+) with people (ages 18+) with (ages 18+) with moderately to moderately to severely moderately to severely moderately to severely severely compromised compromised immune compromised immune compromised immune immune systems who received systems receive an systems receive an systems receive an a primary dose of Johnson &. Updated 6/01/22. additional dose of an additional dose of an additional dose of an Johnson COVID-19 Vaccine to mRNA COVID-19 Vaccine .

7 MRNA COVID-19 Vaccine . mRNA COVID-19 Vaccine . receive an additional dose of an mRNA COVID-19 Vaccine . Dose Volume mL mL Pfizer: mL. Moderna: mL. Minimum Interval 28 days 28 days 28 days 28 days BOOSTER DOSE (FIRST). Authorized for a Yes Yes Yes Yes1. Booster Dose? Recommendation for All individuals (ages 5-11) All individuals (ages 12+) All individuals (ages 18+) All individuals (ages 18+) who booster dose who received the Pfizer who received an mRNA who received an mRNA received a primary dose the of COVID-19 Vaccine for their (Pfizer or Moderna) (Pfizer or Moderna) Johnson & Johnson COVID-19 . primary series. COVID-19 Vaccine for their COVID-19 Vaccine for their Vaccine are recommended to Individuals ages 5-11 primary series.

8 Primary series. receive a booster dose of an years are only Individuals ages 12-17 Adults ages 18 years mRNA (Pfizer or Moderna). authorized to receive years are only and older are COVID-19 Vaccine . However, the Pfizer COVID-19 authorized to receive recommended to the Johnson & Johnson Vaccine . the Pfizer COVID-19 receive an mRNA COVID-19 Vaccine may still be Vaccine . COVID-19 Vaccine . used in some circumstances. Adults ages 18 years and older are recommended to receive an mRNA. COVID-19 Vaccine . Dose 10 mcg 30 mcg 50 mcg4 N/A. Dose volume mL mL mL4 mL. Minimum Interval 5 months 5 months 5 months 2 months Between Primary Series and Booster Dose Minimum Interval 3 months5 3 months5 3 months5 2 months Between Additional Dose (Immunocompromised).

9 And Booster Dose5. Updated 6/01/22. BOOSTER DOSE (SECOND)6. Authorized for a NO Yes Yes NO. Second Booster Dose? Recommendation for N/A Select populations (ages Select populations (ages Select populations (ages Second Booster Dose6 12+) who received an 12+) who received an 12+) who received an mRNA. mRNA (Pfizer or Moderna) mRNA (Pfizer or Moderna) (Pfizer or Moderna) COVID-19 . COVID-19 Vaccine or the COVID-19 Vaccine or the Vaccine or the Johnson &. Johnson & Johnson Johnson & Johnson Johnson COVID-19 Vaccine for COVID-19 Vaccine for their COVID-19 Vaccine for their their first booster dose. first booster dose. first booster dose. All individuals ages 50+. All individuals ages 50+ All individuals ages years.

10 Years. 50+ years. All moderately severely All moderately severely All moderately severely immunocompromised immunocompromised immunocompromised individuals ages 12+ years. individuals ages 12+ individuals ages 12+ Adults ages 18-49 years years. years. who received the Johnson & Johnson COVID-19 . All individuals eligible for a All individuals eligible for a Vaccine for both their second booster dose must second booster dose must primary dose and first receive an mRNA COVID- receive an mRNA COVID- booster dose. 19 Vaccine for their second 19 Vaccine for their second booster dose. booster dose. All individuals eligible for a Individuals ages 12-17 second booster dose must years are only receive an mRNA COVID-19 .